Vidan Diagnostics | Standard of Care for Life
Reagent Application for β-Hydroxybutyrate 21FS Assay Now Available for Roche cobas® Clinical Chemistry Systems
The FREND™ COVID-19 Total Antibody is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
BHB Liquid-stable and Ready-to-use Reagent
Reagent Application for Vidan Diagnostics’
β-Hydroxybutyrate 21FS Assay is now available for
Abbott Alnity™ Clinical Chemistry System.
Vidan Diagnostics Launches Reagent Application for its β-Hydroxybutyrate 21FS Assay on the Siemens Atellica® Clinical Chemistry System.
QCnow™ is a portal to quality control information, providing laboratory personnel with an easy and rapid way to access their quality control data and other QC related information via the internet.
SAN ANTONIO, TEXAS
Elevate patient confidence in clinical decisions through quality results you can trust.
Assist healthcare providers identify patient diseases and conditions early with the best available diagnostic products.
Provide health care payers with smarter clinical and economic decision-making products to test patients
Waiting around is not an option in today’s in vitro diagnostic world. Choose a partner who’s ready to help you adapt to change. Allow us to meet your needs today with our products and help prepare your organization for tomorrow.